Cargando…
Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic
The coronavirus disease 2019 (COVID-19) is an emerging pandemic challenge. Acute respiratory distress syndrome (ARDS) in COVID-19 is characterized by a severe cytokine storm. Patients undergoing glucocorticoid (GC) replacement therapy for adrenal insufficiency (AI) represent a highly vulnerable grou...
Autores principales: | Almeida, Madson Q., Mendonca, Berenice B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Medicina / USP
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279638/ https://www.ncbi.nlm.nih.gov/pubmed/32555949 http://dx.doi.org/10.6061/clinics/2020/e2022 |
Ejemplares similares
-
Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia
por: Lousada, Lia Mesquita, et al.
Publicado: (2021) -
Genetic Diagnosis of Primary Adrenal Insufficiency in Children: A Paradigm Change
por: Almeida, Madson Q
Publicado: (2021) -
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
por: Isidori, Andrea M, et al.
Publicado: (2020) -
Primary malignant tumors of the adrenal glands
por: Almeida, Madson Q, et al.
Publicado: (2018) -
Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency
por: Baek, Jong Ha, et al.
Publicado: (2016)